Merrimack Pharmaceuticals Inc was incorporated in 1993 and reincorporated in the state of Delaware in October 2010. The Company is engaged in discovering, developing and preparing to commercialize medicines consisting of novel therapeutics paired with companion diagnostics for the treatment of cancer. It faces competition from specialty pharmaceutical and biotechnology companies, academic institutions and governmental agencies and public and private research institutions. The Company is subject to rules and regulations from the federal, state and local authorities.
Benzinga is a fast-growing, dynamic and innovative financial media outlet that empowers investors with high-quality, unique content.